DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 80 · 1998 DOI: 10.1055/s-008-36003

Review Articles

  • 1
    Everse, Stephen J.; Spraggon, Glen; Doolittle, Russell F.:

    A Three-Dimensional Consideration of Variant Human Fibrinogens

  • 10
    Zacharski, Leo R.; Ornstein, Deborah L.:

    Heparin and Cancer

  • 24
    Bouma, Bonno N.; von dem Borne, Peter A. Kr.; Meijers, Joost C. M.:

    Factor XI and Protection of the Fibrin Clot against Lysis – a Role for the Intrinsic Pathway of Coagulation in Fibrinolysis

    • Rapid Communication

  • 28
    Kuwahara, Mitsuhiro; Sugimoto, Mitsuhiko; Tsuji, Shizuko; Miyata, Shigeki; Nishio, Kenji; Kaku, Seiji; Suzuki, Ken-ichi; Kawasaki, Tomihisa; Yoshioka, Akira:

    Comparative Studies on the Antiplatelet Effects of a Humanized Anti-Platelet Glycoprotein IIb/IIIa Antibody (YM337) and ReoPro under Flow Conditions

  • 32
    Bowen, D. J.; Standen, G. R.; Mazurier, C.; Gaucher, C.; Cumming, A.; Keeney, S.; Bidwell, J.:

    Type 2N von Willebrand Disease: Rapid Genetic Diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F) – Detection of a Novel Candidate Type 2N Mutation: C2810T (R854W)

  • 37
    Romeuf, Christophe de; Mazurier, Claudine:

    Comparison between von Willebrand Factor (VWF) and VWF Antigen II in Normal Individuals and Patients with von Willebrand Disease

  • 42
    Jackson, Denise E.; White, Melanie M.; Jennings, Lisa K.; Newman, Peter J.:

    A Ser162→ Leu Mutation within Glycoprotein (GP) IIIa (Integrin β3) Results in an Unstable αIIbβ3 Complex that Retains Partial Function in a Novel Form of Type II Glanzmann Thrombasthenia

  • 49
    Leroyer, Christophe; Mercier, Bernard; Oger, Emmanuel; Chenu, Eric; Abgrall, Jean-François; Férec, Claude; Mottier, Dominique:

    Prevalence of 20210 A Allele of the Prothrombin Gene in Venous Thromboembolism Patients

  • 52
    Smulders, Ronald A.; Stehouwer, Coen D. A.; Schalkwijk, Casper G.; Donker, Ab J. M.; van Hinsbergh, Victor W. M.; TeKoppele, Johan M.:

    Distinct Associations of HbA1c and the Urinary Excretion of Pentosidine, an Advanced Glycosylation End-product, with Markers of Endothelial Function in Insulin-dependent Diabetes mellitus

  • 58
    Ferroni, P.; Speziale, G.; Ruvolo, G.; Giovannelli, A.; Pulcinelli, F. M.; Lenti, L.; Pignatelli, P.; Criniti, A.; Tonelli, E.; Marino, B.; Gazzaniga, P. P.:

    Platelet Activation and Cytokine Production during Hypothermic Cardiopulmonary Bypass – A Possible Correlation?

  • 65
    Downey, Colin; Kazmi, Rashid; Toh, Cheng Hock:

    Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis

  • 70
    de Groot, Marco R.; Büller, Harry R.; ten Cate, Jan W.; Kooy, Marinus van Marwijk:

    Use of a Heparin Nomogram for Treatment of Patients with Venous Thromboembolism in a Community Hospital

  • 74
    Røjkjær, Rasmus; Hasan, Ahmed A. K.; Motta, Guacyara; Schousboe, Inger; Schmaier, Alvin H.:

    Factor XII Does not Initiate Prekallikrein Activation on Endothelial Cells

  • 82
    Mauron, Thomas; Lämmle, Bernhard; Wuillemin, Walter A.:

    Influence of Low Molecular Weight Heparin and Low Molecular Weight Dextran Sulfate on the Inhibition of Coagulation Factor XIa by Serpins

  • 87
    Liang, Zhong; Cooper, Adrian; DeFord, Melanie E.; Carmeliet, Peter; Collen, Desire; Castellino, Francis J.; Rosen, Elliot D.:

    Cloning and Characterization of a cDNA Encoding Murine Coagulation Factor X

  • 92
    Thorelli, Elisabeth; Kaufman, Randal J.; Dahlbäck, Björn:

    Cleavage Requirements of Factor V in Tissue-factor Induced Thrombin Generation

  • 99
    Robert, A.; Querrec, Le A.; Delahousse, B.; Caron, C.; Houbouyan, L.; Boutière, B.; Horellou, M.H.; Reber, G.; Sié, P.; the Groupe «Méthodologie en Hémostase» du Groupe d’Etudes sur l’Hémostase et la Thrombose:

    Control of Oral Anticoagulation in Patients with the Antiphospholipid Syndrome – Influence of the Lupus Anticoagulant on International Normalized Ratio

  • 104
    Toulon, Pierre; Boutière, Brigitte; Horellou, Marie-Hélène; Trzeciak, Marie Christine; Samama, Meyer M.:

    Monitoring Heparin Therapy Using Activated Partial Thromboplastin Time – Results of a Multicenter Trial Establishing the Therapeutic Range for SILIMAT, a Reagent with High Sensitivity to Heparin

  • 109
    Girard, Pascal; Nony, Patrice; Erhardtsen, Elisabeth; Delair, Sylvie; Ffrench, Patrick; Dechavanne, Marc; Boissel, Jean-Pierre:

    Population Pharmacokinetics of Recombinant Factor VIIa in Volunteers Anticoagulated with Acenocoumarol

  • 114
    DeLa Cadena, Raul A.; Majluf-Cruz, Abraham; Stadnicki, Antoni; Tropea, Margaret; Reda, Debra; Agosti, Jan M.; Colman, Robert W.; Suffredini, Anthony F.:

    Recombinant Tumor Necrosis Factor Receptor p75 Fusion Protein (TNFR:Fc) Alters Endotoxin-Induced Activation of the Kinin, Fibrinolytic, and Coagulation Systems in Normal Humans

  • 119
    Chu, Michael; Bird, Catherina H.; Teasdale, Melvena; Bird, Phillip I.:

    Turnover of Thrombomodulin at the Cell Surface Occurs at a Similar Rate to Receptors that Are Not Actively Internalized

  • 128
    Cain, Dean; Hutson, Susan M.; Wallin, Reidar:

    Warfarin Resistance Is Associated with a Protein Component of the Vitamin K 2,3-Epoxide Reductase Enzyme Complex in Rat Liver

  • 134
    Sakkinen, Pamela A.; Cushman, Mary; Psaty, Bruce M.; Kuller, Lewis H.; Bajaj, S. Paul; Sabharwal, Arun K.; Boineau, Robin; Macy, Elizabeth; Tracy, Russell P.:

    Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort

  • 140
    Okada, S. Steve; Golden, Michael A.; Raghunath, P. N.; Tomaszewski, John E.; David, Mary L.; Kuo, Alice; Kariko, Katalin; Barnathan, Elliot S.:

    Native Atherosclerosis and Vein Graft Arterialization: Association with Increased Urokinase Receptor Expression In Vitro and In Vivo

  • 148
    Fowler, Bruce; Mackman, Nigel; Parmer, Robert J.; Miles, Lindsey A.:

    Binding of Human Single Chain Urokinase to Chinese Hamster Ovary Cells and Cloning of Hamster u-PAR

  • 155
    Chudzinski-Tavassi, Ana Marisa; Kelen, Eva Maria A.; Rosa, Ana Paula de Paula; Loyau, Stephane; Sampaio, Claudio A. M.; Bon, Cassian; Anglés-Cano, Eduardo:

    Fibrino(geno)lytic Properties of Purified Hementerin, a Metalloproteinase from the Leech Haementeria depressa

  • 161
    Urano, Tetsumei; Nagai, Nobuo; Matsuura, Megumi; Ihara, Hayato; Takada, Yumiko; Takada, Akikazu:

    Human Thrombin and Calcium Bound Factor Xa Significantly Shorten tPA-Induced Fibrin Clot Lysis Time via Neutralization of Plasminogen Activator Inhibitor Type 1 Activity

  • 167
    Biasiutti, F. Demarmels; Sulzer, I.; Stucki, B.; Wuillemin, W. A.; Furlan, M.; Lämmle, B.:

    Is Plasminogen Deficiency a Thrombotic Risk Factor ? – A Study on 23 Thrombophilic Patients and their Family Members

  • 171
    Wartiovaara, Ulla; Salven, Petri; Mikkola, Hanna; Lassila, Riitta; Kaukonen, Jaakko; Joukov, Vladimir; Orpana, Arto; Ristimäki, Ari; Heikinheimo, Markku; Joensuu, Heikki; Alitalo, Kari; Palotie, Aarno:

    Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation

  • 176
    Callan, Mary Beth; Shofer, Frances S.; Wojenski, Carol; Giger, Urs:

    Chrono-lume® and Magnesium Potentiate Aggregation of Canine but not Human Platelets in Citrated Platelet-Rich Plasma

  • 181
    Tamai, Yoshiko; Takami, Hideki; Nakahata, Rieko; Nakui, Yuka; Akagi, Tomoaki; Munakata, Akihiro:

    Development and Practical Use of the New Quantitative Bleeding Time Test Apparatus

  • 186
    Deschênes, Isabelle; Finkle, Carolyn D.; Winocour, Peter D.:

    Effective Use of BCH-2763, a New Potent Injectable Direct Thrombin Inhibitor, in Combination with Tissue Plasminogen Activator (tPA) in a Rat Arterial Thrombolysis Model

  • 192
    Dickneite, Gerhard; Nicolay, Uwe; Friesen, Heinz-Jürgen; Reers, Martin:

    Development of an Anti-Bleeding Agent for Recombinant Hirudin Induced Skin Bleeding in the Pig

    • Letters to the Editor

  • 199
    Lethagen, S.; Frick, K.; Isaksson, C.; Kristoffersson, A.-C.; Holmberg, L.:

    Revised Classification and Treatment of von Willebrand Disease

  • 200
    Morita, Hiroyuki; Kurihara, Hiroki; Taguchi, Jun-ichi; Ohno, Minoru; Yazaki, Yoshio:

    ACE and MTHFR Gene Polymorphisms: Genetic Coronary Risk Factors Relating to Different Aspects of Pathophysiology

  • 201
    Veyradier, Agnès; Wolf, Martine; Boyer-Neumann, Catherine; Parent, Florence; Simonneau, Gérald; Meyer, Dominique:

    Recurrent Thromboembolism in Two Unrelated Patients with Double Heterozygosity for Factor V R506Q and Factor II 20210G/A Mutations

  • 202
    Bertolaccini, M. L.; Atsumi, T.; Hunt, B. J.; Amengual, O.; Khamashta, M. A.; Hughes, G. R. V.:

    Prothrombin Mutation Is not Associated with Thrombosis in Patients with Antiphospholipid Syndrome

  • 203
    Shibata, Yuhki; Hashimoto, Hisakuni; Kurata, Chinori; Ohno, Ryuzo; Kazui, Teruhisa; Takinami, Makoto:

    Influence of Physical Activity on Warfarin Therapy

  • 204
    Meijer, K.; Sieders, E.; Slooff, M. J. H.; de Wolf, J. Th. M.; van der Meer, J.:

    Effective Treatment of Severe Bleeding due to Acquired Thrombocytopathia by Single Dose Administration of Activated Recombinant Factor VII

  • 206
    Girolami, Antonio:

    Idiopathic Versus Secondary Thrombosis as a Predictive Marker of Occult Malignancy

  • 207
    Weber, Artur-Aron; Schrör, Karsten:

    Complex Control of Vascular Smooth Muscle Cell Growth by Thromboxane A2

  • 208
    Karmochkine, Marina; Ankri, Annick; Calvez, Vincent; Bonmarchant, Manuela; Coutellier, Anne; Herson, Serge:

    Plasma Hypercoagulability Is Correlated to Plasma HIV Load*

  • 209
    Grant, Peter J.:

    Metformin Reduces Circulating Factor VII Concentrations in Patients with Type 2 Diabetes mellitus